Should multiorificed central venous catheters be heparin bonded? 1988

J H Donegan, and S Rupp

UI MeSH Term Description Entries
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D002405 Catheterization, Central Venous Placement of an intravenous CATHETER in the subclavian, jugular, or other central vein. Central Venous Catheterization,Venous Catheterization, Central,Catheterization, Central,Central Catheterization,Catheterizations, Central,Catheterizations, Central Venous,Central Catheterizations,Central Venous Catheterizations,Venous Catheterizations, Central
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J H Donegan, and S Rupp
October 2007, The Cochrane database of systematic reviews,
J H Donegan, and S Rupp
February 2014, The Cochrane database of systematic reviews,
J H Donegan, and S Rupp
July 2021, British journal of hospital medicine (London, England : 2005),
J H Donegan, and S Rupp
February 2004, Critical care (London, England),
J H Donegan, and S Rupp
October 1995, BMJ (Clinical research ed.),
J H Donegan, and S Rupp
September 1999, Anaesthesia,
J H Donegan, and S Rupp
October 1984, American journal of hospital pharmacy,
J H Donegan, and S Rupp
December 2013, BMJ (Clinical research ed.),
Copied contents to your clipboard!